FDA Inspection 1078089 — Wisdom Pharmaceutical Co., Ltd.

Wisdom Pharmaceutical Co., Ltd. — FEI 3004486763

The FDA completed an inspection of Wisdom Pharmaceutical Co., Ltd. on Jan 18, 2019 in Haimen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 18, 2019
Fiscal Year
2019
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Haimen (China)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
430321 CFR 211.67(b)Written procedures fail to include